Off-label DOAC Dosing Common in Hospitalized AF Patients, To

There remains room for improvement, despite a decline in use of nonrecommended dosing over time, a researcher says.

Related Keywords

Philadelphia , Pennsylvania , United States , American , Ramneet Sandhu , Bayer Janssen , Boehringer Ingelheim , Md University Of Colorado Hospital , Bristol Myers Squibb , American Heart Association , Colorado Hospital , Cardiovascular Quality , With The Guidelines , Get With The Guidelines ,